Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
AGBAR
|
Brian Chung Yau Chan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 500,000 Added 45.81% |
-
|
Oct 21
2025 |
|
AGBAR
|
Thomas Kwok On Ng
Director |
BUY
Grant, award, or other acquisition
|
Direct | 500,000 Added 43.29% |
-
|
Oct 21
2025 |
|
AGBAR
|
Yun Pun Felix Wong
Director |
BUY
Grant, award, or other acquisition
|
Direct | 500,000 Added 45.61% |
-
|
Oct 21
2025 |
|
AGBAR
|
Wing Fai Ng
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 4,000,000 Added 26.08% |
-
|
Oct 21
2025 |
|
AGBAR
|
Pei Huang Desmond Shu
Acting Group CFO |
BUY
Grant, award, or other acquisition
|
Direct | 2,000,000 Added 44.35% |
-
|
Oct 21
2025 |
|
DGX
|
Mark E Delaney
SVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 15 Added 0.2% |
$2,836
$189.08 p/Share
|
Oct 21
2025 |
|
DGX
|
Vicky B Gregg
Director |
BUY
Grant, award, or other acquisition
|
Direct | 70 Added 0.38% |
$13,235
$189.08 p/Share
|
Oct 21
2025 |
|
DGX
|
Karthik Kuppusamy
SVP, Clinical Solutions |
BUY
Grant, award, or other acquisition
|
Direct | 15 Added 0.18% |
$2,836
$189.08 p/Share
|
Oct 21
2025 |
|
DGX
|
Patrick Plewman
SVP for Diagnostic Services |
BUY
Grant, award, or other acquisition
|
Direct | 46 Added 0.3% |
$8,697
$189.08 p/Share
|
Oct 21
2025 |
|
DGX
|
Sam Samad
Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 68 Added 0.26% |
$12,857
$189.08 p/Share
|
Oct 21
2025 |
|
DGX
|
Robert B Carter
Director |
BUY
Grant, award, or other acquisition
|
Direct | 6 Added 0.22% |
$1,134
$189.09 p/Share
|
Oct 21
2025 |
|
RENT
|
Michael Roth
Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct | 13,169 Added 33.76% |
$53,729
$4.08 p/Share
|
Oct 21
2025 |
|
BLBX
|
Charles Keller Reid
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 23.48% |
$46,200
$9.24 p/Share
|
Oct 21
2025 |
|
EVCM
|
Eric Richard Remer
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 11,735 Reduced 0.39% |
$134,248
$11.44 p/Share
|
Oct 21
2025 |
|
SMMT
|
Yu Xia
Director |
BUY
Open market or private purchase
|
Indirect | 533,617 Added 0.0% |
$9,999,982
$18.74 p/Share
|
Oct 21
2025 |
|
ORCL
|
Maria Smith
EVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 8.76% |
$1,400,000
$280.0 p/Share
|
Oct 21
2025 |
|
ORCL
|
Clayton M. Magouyrk
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 20.62% |
$11,065,600
$276.64 p/Share
|
Oct 21
2025 |
|
PCOR
|
Howard Fu
CFO & Treasurer |
SELL
Open market or private sale
|
Direct | 814 Reduced 0.43% |
$58,884
$72.34 p/Share
|
Oct 21
2025 |
|
BNOX
|
Lynx1 Capital Management LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 639,110 Added 0.0% |
$3,285,025
$5.14 p/Share
|
Oct 21
2025 |
|
NVDA
|
Colette Kress
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.0% |
$3,625,800
$181.29 p/Share
|
Oct 21
2025 |
|
NVDA
|
Colette Kress
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 27,640 Reduced 0.96% |
$5,010,855
$181.29 p/Share
|
Oct 21
2025 |
|
NVDA
|
Jen Hsun Huang
President and CEO |
SELL
Open market or private sale
|
Direct | 75,000 Reduced 0.11% |
$13,601,250
$181.35 p/Share
|
Oct 21
2025 |
|
SOTK
|
Christopher L Coccio
Director |
SELL
Open market or private sale
|
Direct | 4,312 Reduced 1.32% |
$20,093
$4.66 p/Share
|
Oct 21
2025 |
|
SFIX
|
Casey O'Connor
Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 149,068 Added 20.43% |
-
|
Oct 21
2025 |
|
SFIX
|
Anthony Bacos
Chief Prod/Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct | 258,799 Added 20.15% |
-
|
Oct 21
2025 |
|
SFIX
|
David Aufderhaar
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 310,559 Added 20.32% |
-
|
Oct 21
2025 |
|
ALLO
|
Geoffrey M. Parker
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 36,744 Reduced 2.8% |
$46,297
$1.26 p/Share
|
Oct 21
2025 |
|
CYCC
|
Diversified Berhad Fitters
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 92,352 Reduced 24.85% |
$277,056
$3.0 p/Share
|
Oct 21
2025 |
|
META
|
Jennifer Newstead
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 519 Reduced 1.8% |
$382,176
$736.37 p/Share
|
Oct 21
2025 |
|
HEI-A
|
Mark H Hildebrandt
Director |
BUY
Open market or private purchase
|
Indirect | 400 Added 0.0% |
$99,504
$248.76 p/Share
|
Oct 21
2025 |
|
IHT
|
James F Wirth
President & CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.16% |
$145,070,000
$14507.0 p/Share
|
Oct 21
2025 |
|
HUBS
|
Brian Halligan |
BUY
Exercise of conversion of derivative security
|
Direct | 263 Added 0.05% |
$100,763
$383.13 p/Share
|
Oct 21
2025 |
|
HUBS
|
Brian Halligan |
SELL
Open market or private sale
|
Direct | 8,265 Reduced 1.58% |
$3,694,289
$446.98 p/Share
|
Oct 21
2025 |
|
PEGA
|
Alan Trefler
C.E.O. & Chairman |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 0.1% |
$2,529,450
$56.21 p/Share
|
Oct 21
2025 |
|
VST
|
James A Burke
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 4,400 Added 1.48% |
$86,592
$19.68 p/Share
|
Oct 21
2025 |
|
VST
|
James A Burke
President and CEO |
SELL
Open market or private sale
|
Direct | 2,005 Reduced 0.69% |
$387,265
$193.15 p/Share
|
Oct 21
2025 |
|
IOT
|
Sanjit Biswas
CHIEF EXECUTVE OFFICER |
SELL
Open market or private sale
|
Indirect | 160,000 Reduced 0.0% |
$6,113,600
$38.21 p/Share
|
Oct 21
2025 |
|
VRSN
|
D James Bidzos
Exec. Chairman, Pres, & CEO |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.07% |
$1,337,400
$267.48 p/Share
|
Oct 21
2025 |
|
IVDA
|
Robert Gillen
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 20,331 Reduced 100.0% |
$26,023
$1.28 p/Share
|
Oct 21
2025 |
|
IOT
|
John Bicket |
SELL
Open market or private sale
|
Indirect | 170,000 Reduced 0.0% |
$6,490,600
$38.18 p/Share
|
Oct 21
2025 |
|
ALLY
|
Russell E. Hutchinson
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 10,600 Reduced 4.72% |
$429,300
$40.5 p/Share
|
Oct 21
2025 |
|
ALLY
|
Kathleen L. Patterson
Chief HR & Corp Citizenship |
SELL
Payment of exercise price or tax liability
|
Direct | 15,524 Reduced 10.73% |
$628,722
$40.5 p/Share
|
Oct 21
2025 |
|
ALLY
|
Stephanie N Richard
Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,543 Reduced 5.03% |
$183,991
$40.5 p/Share
|
Oct 21
2025 |
|
ALLY
|
Douglas R. Timmerman
President, DFS |
SELL
Payment of exercise price or tax liability
|
Direct | 49,386 Reduced 9.2% |
$2,000,133
$40.5 p/Share
|
Oct 21
2025 |
|
ASAN
|
Justin Rosenstein
Director |
SELL
Open market or private sale
|
Direct | 458,878 Reduced 29.77% |
$6,873,992
$14.98 p/Share
|
Oct 21
2025 |
|
MLSS
|
S.R.L. Bp4
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 0.44% |
$17,600
$0.44 p/Share
|
Oct 21
2025 |
|
HOOD
|
Baiju Bhatt
Director |
SELL
Open market or private sale
|
Indirect | 418,338 Reduced 0.0% |
$55,781,188
$133.34 p/Share
|
Oct 21
2025 |
|
HOOD
|
Baiju Bhatt
Director |
BUY
Conversion of derivative security
|
Indirect | 418,338 Added 0.0% |
-
|
Oct 21
2025 |
|
STUB
|
Scott Michael Fitzgerald
Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 731 Reduced 0.64% |
$13,918
$19.04 p/Share
|
Oct 21
2025 |
|
RMCF
|
Global Value Investment Corp. |
BUY
Open market or private purchase
|
Indirect | 14,562 Added 0.0% |
$24,027
$1.65 p/Share
|
Oct 21
2025 |